Shire plc (SHPGY) Reports Vyvanse Met Primary Endpoint in Phase II for MDD Treatment
Go back to Shire plc (SHPGY) Reports Vyvanse Met Primary Endpoint in Phase II for MDD Treatment| Shire pic (NASDAQ: SHPGY) | Delayed: 85.67 -0.17 (0.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.84 | 52 Week High | $108.79 | |||
| Open | $86.18 | 52 Week Low | $80.09 | |||
| Day High | $86.44 | P/E | N/A | |||
| Day Low | $85.57 | EPS | $0.00 | |||
| Volume | 196,308 | |||||
